

share
Repirinast CAS NO 73080-51-0
Unit Price:
CAS No.:73080-51-0
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Repirinast is a selective phosphodiesterase 4 (PDE4) inhibitor with significant anti-inflammatory and anti-allergic properties. This compound is a key intermediate in the synthesis of advanced pharmaceutical actives targeting respiratory and inflammatory conditions. It is primarily utilized by pharmaceutical R&D departments and fine chemical manufacturers engaged in the development of next-generation therapeutics. The material is supplied to meet the stringent requirements of global regulatory and quality standards.
Application
- Pharmaceutical Intermediate: Critical building block for the synthesis of novel PDE4 inhibitor drugs.
- Anti-allergic Drug Research: Used in preclinical and clinical research for developing treatments for asthma, allergic rhinitis, and atopic dermatitis.
- Inflammation Research: Serves as a reference standard and active component in studies targeting chronic inflammatory diseases.
- Fine Chemical Synthesis: Employed in custom synthesis and process development for high-value active pharmaceutical ingredients (APIs).
- Biochemical Tool: Used as a selective PDE4 enzyme inhibitor in biochemical assays and pharmacological studies.
Basic Information
| Product Name | Repirinast |
| CAS No. | 73080-51-0 |
| Molecular Formula | C20H21NO5 |
| Molecular Weight | 355.39 g/mol |
| Synonyms | 6,7-Dihydro-8-propyl-2-(4-pyridinyl)-4H-pyrazolo[1,5-a][1,3,5]triazin-4-one; MY-5116; Repirinastum; Repirinasto; Repirinast (USAN); 8-Propyl-2-(4-pyridinyl)-6,7-dihydro-4H-pyrazolo[1,5-a][1,3,5]triazin-4-one |
| EINECS | Contact for details |
Quality Control
Our Repirinast is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We support compliance with cGMP, ICH Q7, and other relevant pharmaceutical guidelines for advanced intermediates. Specifications can be tailored to meet specific project requirements upon request.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to maintain stability.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification (IR) | Conforms to structure |
| Identification (HPLC) | Conforms to reference |
| Assay (HPLC) | ≥98.0% |
| Related Substances (HPLC) | Total impurities ≤2.0% |
| Single Unknown Impurity | ≤0.5% |
| Residual Solvents (GC) | Meets ICH Q3C guidelines |
| Loss on Drying | ≤0.5% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Tranilast CAS NO 53902-12-8


Pemirolast Potassium CAS NO 100299-08-9


Quinotolast CAS NO 101193-40-2


Tranilast (Sodium) CAS NO 104931-56-8


Pirodomast CAS NO 108310-20-9


Allay Gel CAS NO 110400-56-1


Acitazanolast CAS NO 114607-46-4


Bepafant CAS NO 114776-28-2


Ramatroban CAS NO 116649-85-5


Setipafant CAS NO 132418-35-0


Tetrazolast Meglumine [Usan] CAS NO 133008-33-0


4-(8-Chloro-6,11-Dihydro-11-Hydroxy-5H-Benzo[5,6]Cyclohepta[1,2-B]Pyridin-11-Yl)-1-Piperidinecarboxylic Acid Ethyl Ester CAS NO 133284-74-9


Deltibant CAS NO 140661-97-8


Ramatroban CAS NO 141281-95-0


Ticolubant CAS NO 154413-61-3


Cp-105,696 CAS NO 158081-99-3


Icrocaptide CAS NO 169543-49-1


Ataquimast CAS NO 182316-31-0


Mk-7246 CAS NO 1218918-62-7


Cipralisant CAS NO 213027-19-1
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






